REPRIEVE: Pitavastatin to Prevent Cardiovascular Disease in HIV

REPRIEVE: Pitavastatin to Prevent Cardiovascular Disease in HIV

HIV patients are known to have up to a two-fold increase in heart-related events, compared with the general population. Could treatment with statins reduce this risk?

Dr. Steven Fine, an infectious disease specialist affiliated with the University of Rochester, reviews the recently published results of the REPRIEVE trial. The big picture is a 35% reduction in heart-related events. Dr. Fine digs into the details and statistics of the trial, and the encouraging results of statin treatment, even in those deemed to be at lower risk. Related Content:

Episoder(58)

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
foreldreradet
merry-quizmas
dopet
jakt-og-fiskepodden
rss-sunn-okonomi
podme-bio-3
rss-strid-de-norske-borgerkrigene
hverdagspsyken
sovnlos
rss-kull
sinnsyn
gravid-uke-for-uke
tomprat-med-gunnar-tjomlid
rss-var-forste-kaffe
dypdykk
rss-kunsten-a-leve